Pfizer: Dwarfism, Pituitary trials

The registry lists 17 Dwarfism, Pituitary studies with Pfizer as lead sponsor. 1 are open to participants now and 8 have results posted.

Phase 2 2Phase 3 7Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.RecruitingNCT06587035
• Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHDCompletedNCT03831880Phase 3Results posted
• A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) PatientsCompletedNCT01947894Results posted
• Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult SubjectsCompletedNCT01112865Phase 3Results posted
• Genotropin Study Assessing Use of Injection PenCompletedNCT00965484Phase 3Results posted
• Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone DeficiencyTerminatedNCT00630487Phase 3Results posted
• Drug Use Investigation of Somatropin for GHD-ADULTS.CompletedNCT00601419Results posted
• Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain InjuryTerminatedNCT00555009Phase 4Results posted
• Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By GenotonormCompletedNCT00163189Phase 3Results posted
• A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth HormoneWithdrawnNCT06113952
• Ngenla Subcutaneous Injection Special InvestigationActive, not recruitingNCT05602766
• A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head InjuryTerminatedNCT00638053Phase 4
• A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone DeficiencyTerminatedNCT00314938Phase 2
• A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone DeficiencyTerminatedNCT00308464Phase 2
• Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature SecondaryCompletedNCT00174278Phase 3
• Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient AdolescentsCompletedNCT00156143Phase 3
• IGF1 Generation TestCompletedNCT00145457Phase 4